Lorlatinib Tablet — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Lorlatinib Tablet (tablet) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Jun 15, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0069-0227-03
Dosage Form
Tablet
Presentation
Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)
Initial Posting
Jun 15, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.